[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cldn6-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"CLDN6 Gene",5,[7,15,22,28,34],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07322094","CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:15:23.202838Z","2026-07-19T19:36:05.068641Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06803680","A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors",[19],"Phase 1","2026-08-26T02:16:46.951087Z","2026-07-05T05:32:16.694406Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT05103683","First in Human Study of TORL-1-23 in Participants With Advanced Cancer",[19],"2026-08-26T02:18:46.137046Z","2026-05-05T02:43:28.638713Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT06515613","A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors",[19],"2026-08-26T02:17:39.048487Z","2026-05-05T02:43:27.324235Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":38,"content_modified":39},"NCT06276491","Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors",[19],"2026-08-26T02:19:19.162260Z","2026-07-05T05:32:16.747857Z"]